Menu
Search
|

Menu

Close
X

Qinghai Spring Medicinal Resources Technology Co Ltd 600381.SS (Shanghai Stock Exchange)

5.73 CNY
+0.08 (+1.42%)
As of Oct 19
chart
Previous Close 5.65
Open 5.46
Volume 2,413,842
3m Avg Volume 2,438,930
Today’s High 5.78
Today’s Low 5.39
52 Week High 13.40
52 Week Low 5.39
Shares Outstanding (mil) 588.08
Market Capitalization (mil) 3,987.15
Forward P/E 12.72
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, CNY)
FY18
189
FY17
471
FY16
708
FY15
1,402
EPS (CNY)
FY18
0.131
FY17
0.525
FY16
0.472
FY15
0.528
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
12.72
11.91
Price to Sales (TTM)
vs sector
9.03
12.95
Price to Book (MRQ)
vs sector
1.79
1.80
Price to Cash Flow (TTM)
vs sector
--
7.54
Total Debt to Equity (MRQ)
vs sector
0.00
34.33
LT Debt to Equity (MRQ)
vs sector
0.00
28.21
Return on Investment (TTM)
vs sector
13.28
15.13
Return on Equity (TTM)
vs sector
13.83
17.74

EXECUTIVE LEADERSHIP

Xuefeng Zhang
Chairman of the Board, General Manager, Since 2017
Salary: --
Bonus: --
Lin Wang
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Xiaodong Li
General Manager, Director, Since
Salary: --
Bonus: --
Haijie Ma
Secretary of the Board, Director, Since
Salary: --
Bonus: --
Zhi Liao
Director, Since 2013
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Energy
Industry: Coal
Address:

16F, Ningjing Business Center
XINING   QNG   810007

Phone: +86971.8816171

QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD is a China-based company that principally engaged in the integrated development, utilization, production, sales and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company’s main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Company’s subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.

SPONSORED STORIES